Abstract
Muscarinic receptors exist in both peripheral tissues and the central nervous system. Their activation is responsible for all the effects elicited by parasympathetic stimulation in the peripheral organs and modulate ganglionic transmission (Wallis, 1979). In the central nervous system muscarinic receptors are involved in many functions connected with the cognitive processes, sleep mechanism, motility, blood pressure and water intake regulation (Karczmar, 1981).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alberts, P., Bartfai, T and Stjärne, L., 1982, The effects of atropine on 3H acetylcholine secretion from guinea—pig myenteric plexus evoked electrically or by high potassium, J. Physiol.(Lond.), 329: 93.
Aronstam, R.S., Triggle,D.J. and Eldefrawi, M.E., 1979, Structural and stereochemical requirements for muscarinic receptor binding, Mol. Pharmacol., 15: 227.
Bartus, R.T., Dean, R.L., Beer, B. and Lippa, A.S., 1982, The cholinergic hypothesis of geriatric memory disfunction, Science, 217: 408.
Beld, A.J. and Ariens, E.J., 1974, Stereospecific binding as a tool in attempts to localize and isolate muscarinic receptors, Eur. J. Pharmac., 25: 203.
Ben—Barak, J. and Dudai, Y., 1980, Scopolamine induces an increase in muscarinic receptor level in rat hippo—campus, Brain Res., 193: 309.
Birdsall, N.J.M.,and Hulme, E.C., 1976, Biochemical studies on muscarinic acetylcholine receptors, J. Neurochem., 27: 7.
Birdsall, N.J.M., Burgen, A.S.V.,and Hulme, E.C., 1977, Correlation between the binding properties and pharmacological responses of muscarinic receptors, in: “Cholinergic mechanisms and psychopharmacology”, D.J. Jenden, ed., Plenum Press, New York.
Birdsall, N.J.M., Burgen, A.S.V.,and Hulme, E.C., 1978, The binding of agonists to brain muscarinic receptors, Mol. Pharmacol., 14: 723.
Bowen, D.M. and Marek, K.L., 1982, Evidence for the pharmacological similarity between central presynaptic muscarinic autoreceptors and postsynaptic muscarinic receptors, Br. J. Pharmac., 75: 367.
Brimblecombe, R.W., 1974, “Drug action on cholinergic systems”, The Macmillan Press, London.
Burgisser, E., De Lean, A.,and Lefkowitz, R.J., 1982, Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide, Proc. Natl. Acad. Sci. U.S.A., 79: 1732.
Campbell, B.A., Lytle, L.D., and Fibiger, H.C., 1969, Ontogeny of adrenergic arousal and cholinergic inhibitory mechanisms in the rat, Science, 166: 635
Casamenti, F., Pedata,F., Corradetti, R., and Pepeu, G., 1980, Acetylcholine output from the cerebral cortex, choline uptake and muscarinic receptors in morphine—dependent freely—moving rats, Neuropharmacol.,19: 597.
Costa, L.G., Schwab, B.W., and Murphy, S.D., 1982, Differential alterations of cholinergic muscarinic receptors during chronic and acute tolerance to organophosphorus insecticides, Biochem. Pharmacol., 31: 3407.
Creese, I., Usdin, T.B., and Snyder, S.H., 1979, Dopamine receptor binding regulated by guanine nucleotides, Mol. Pharmacol., 16: 69.
Ehlert, ?.J., Kokka, N., and Fairhurst, A.S., 1980, Altered H quinuclidinyl benzylate binding in the striatum following chronic cholinesterase inhibition with diisopropylfluorophosphate, Mol. Pharmacol., 17: 24.
Fozard, J.R. and Muscholl, E., 1972, Effects of several muscarinic agonists on cardiac performance and the release of noradrenaline from sympathetic nerves of the perfused rabbit heart, Br. J. Pharmac., 45: 616.
Furchgott, R.F., 1978, Pharmacological characterization of receptors: its relation to radioligand—binding studies, Fedn. Proc., 37: 115.
Gazit, H., Silman, I., and Dudai, Y., 1979, Administration of an organophosphate causes a decrease in mus — carinic receptor level in rat brain, Brain Res., 174: 351.
Hammer, R., Berrie, C.P., Birdsall, N.J.M., Burgen, A. S.V., and Hulme, E.C., 1980, Pirenzepine distinguishes between different “subclasses of muscarinic receptors, Nature, 283: 90.
Hammer, R. and Giachetti, A., 1982, Muscarinic receptor subtypes: M1 and M. Biochemical and functional charac— terization, Life Seei., 31: 2991.
Hartzell, H.C., 1982, Physiological consequences of muscarinic receptor activation, Trends Pharmacol. Sci.
Heilbronn, E. and Bartfai, T., 1978, Muscarinic acetylcholine receptors, Progr. Neurobiol., 11: 171.
Heilbronn, E. and Bartfai, T., 1978, Muscarinic acetylcholine receptors, Progr. Neurobiol., 11: 171.
Hulme, E.C., Birdsall, N.J.M., Burgen, A.S.V., and Mehta, P., 1978, The binding of antagonists to brain muscarinic receptors, Mol. Pharmacol., 14: 737.
Karczmar, A.G., 1981, Basic phenomena underlying novel use of cholinergic agents, anticholinesterases and precursors in neurological including peripheral and psychiatric diseases, in: “Cholinergic mechanisms”, G. Pepeu and H. Ladins y eds., Plenum Press, New York.
Kilbinger, H. and Wessler, I., 1980, Pre and post—synaptic effects of muscarinic agonists in the guinea—pig ileaum, Naunyn—Schmiedeberg’s Arch. Pharmacol., 314: 259.
Kuhar, M.J. and Yamamura, H.I., 1975, Light autoradio—graphic localization of cholinergic muscarinic receptors in rat brain by specific binding of a potent antagonist, Nature, 253: 560.
Kuhar, M.J., Birdsall, N.J.M., Burgen, A.S.V. and Hulme, E.C., 1980, Ontogeny of muscarinic receptors in rat brain, Brain Res., 184: 375•
Kuo, J.F., 1974, Guanosine 3’ 5’- monophosphate—dependent protein kinases in mammalian tissues, Proc. Natl. Acad. Sci. U.S.A., 71: 4037.
Laduron, P., 1980, Axoplasmic transport of muscarinic receptors, Nature, 286: 287.
Laduron, P., Verwimp, M, and Leysen, J.E., 1979
Stereospecific in vitro binding of3H dexetimide to brain muscarinic receptors, J. Neurochem., 32: 421.
Lundberg, J.M., 1981, Evidence for coesistence of vasoactive intestinal polypeptide (VIP) and acetylcholine
in neurons of cat exocrine glands, Acta Physiol. Scand., Suppl. 496: 1.
Lundberg, J.M., Hedlund, B., and Bartfai, T., 1982, Vasoactive intestinal polypeptide enhances muscarinic ligand binding in cat submandibular salivary gland, Nature, 295: 147.
Majocha, R. and Baldessarini, R.J., 1980, Increased muscarinic receptor binding in rat forebrain after scopolamine, European J. Pharmacol., 67: 327.
Matsuzawa, H. and Nirenberg, M., 1975, Receptor mediated shift in cGMP and cAMP levels in neuroblastoma cells, Proc. Natl. Acad. Sci. U.S.A., 72: 3472.
McKinney and Coyle, J.T., 1982, Regulation of neocortical muscarinic receptors: effect of drug treatment and lesions, J. Neurosci., 2: 97.
Mitchell, R.H. and Kirk, C.J., 1981, Why is phosphatidylinositol degraded in responses to stimulation of certain receptors ?, Trends Pharmacol. Sci., 2: 86.
Nordberg, A., Wahlström, G and Larsson, Ch., 1980, Increased number of muscarinic binding sites in brain following chronic barbiturate treatment to rat, Life Sci., 26: 231.
Nordström, 0. and Bartfai, T., 1980, Muscarinic auto—receptor regulates acetylcholine in rat hippocampus: in vitro evidence, Acta Physiol., 108: 347.
Nordström, 0;, Alberts, P., Westlind, A., Unden, A., and Bartfai, T., 1983, Presynaptic antagonist — post—synaptic agonist at muscarinic cholinergic synapses:
N—methyl—N—(1—methyl-4—pyrrolidino-2—butynyl) acetamide, Mol. Pharmacol., in the press.
Parry, M. and Heathcote, B.V., 1982, A comparison of the effec of pirenzepine and atropine on gastric acid secretion, salivary secretion and pupil diameter in the rat. Life Sci., 31: 1465.
Patel, A.J., Smith, R.M., Kingsbury, A.E., Hunt, A., and Balazs, R., 1980, Effects of thyroid state on brain
development: muscarinic acetylcholine and GABA receptors, Brain Res., 198: 389.
Paton, W.D.M. and Rang, H.P., 1965, The uptake of atropine and related drugs by intestinal smooth muscle of the guinea—pig in relation to acetylcholine receptors, Proc. R. Soc. B, 163: 1.
Pedata, F., Slavikova, J., Kotas,A., and Pepeu, G., 1983, Acetylcholine release from rat cortical slices during postnatal development and aging, Neurobiol. Aging, in the press.
Polak, R.L. and Meeuws, M.M., 1966, The influence of atropine on the release and uptake of acetylcholine by the isolated cerebral cortex of the rat, Biochem. Pharmacol., 15: 989.
Putney, J.W. and Van De Walle, C., 1980, The relationship between muscarinic receptor binding and ion movements in rat parotid cells, J. Physiol. (Lond.), 299: 521.
Rosenberger,L.B.,Roeske, W.R., and Yamamura, H.I., 1979, The regulation of muscarinic receptors by guanine nucleotides in cardiac tissue, European J. Pharmacol., 56: 179.
Rosenberger, L.B., Yamamura, H.I., and Roeske, W.R., 1980 The regulation of cardiac muscarinic receptors by isoproterenol, European J. Pharmacol., 65: 129.
Siman, R.G. and Klein, W.L., 1981, Specificity of muscarinic acetylcholine receptor regulation by receptor activity, J. Neurochem., 37: 1099.
Siman, R.G., and Klein, W.L., 1979, Cholinergic activity regulates muscarinic receptors in central nervous system cultures, Proc, Natl. Acad. Sci. U.S.A., 76: 4141.
Snyder, S.H., Chang, K.J., Kuhar, M.J., and Yamamura, H.I., 1975, Biochemical identification of the mammalian muscarinic cholinergic receptor, Fedn. Proc., 34: 1915.
Sokolovsky, M., Gurwitz, D., and Galron, R., 1980, Muscarinic receptor binding in mouse brain: regulation by guanine nucleotides, Biochem. Biophys. Res. Comm., 94: 487.
Szelenyi, I., 1982, Does pirenzepine distinguish between “subtypes” of muscarinic receptors ?, Br. J. Pharmac., 77: 567.
Szerb, J.C. and Somogyi, C.T., 1973, Depression of acetylcholine release in cerebral cortical slices by cholinesterase inhibition and by oxotremorine, Nature, 241: 121.
Wallis, D.I., 1979, The apparent multiplicity of ganglionic receptors, in:“Trends in autonomic pharmacology”, I, Kalsner ed., Urban and Schwarzenberg, Baltimore.
Wamsley, J.K., Zarbin, M.A., and Kuhar, M.J., 1981, Muscarinic cholinergic receptors flow in the sciatic nerve, Brain Res., 217: 155.
Waser, P.G., 1961, Chemistry and pharmacology of muscarine, muscarone and related compounds, Pharmacol. Rev., 13: 465.
Wastek, G.J. and Yamamura, H.I., 1978, Biochemical characterization of the muscarinic cholinergic receptor in human brain: alteration in Huntington’s disease, Mol. Pharmacol., 14: 768.
Wastek, G.J., Lopez, J.R.,and Richelson, E., 1981, Demonstration of a muscarinic mediated cyclic GMPdependent hyperpolarization of the vembrane potential of mouse neuroblastoma cells using H tetraphenylphosphonium, Mol. Pharmacol., 19: 15.
Watson, M., Roeske, W.R., and Yamamura, H.I., 1982, H pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortex, Life Sci. 31: 2019.
Yamamura, H.I. and Snyder, S.H., 1974, Muscarinic cholinergic binding in rat brain, Proc. Natl. Acad. S.i. U.S.A., 71: 1725.
Yamamura, H.Z., Kuhar, M.J., Greenberg, D., and Snyder, S.H., 1974, Muscarinic cholinergic receptor binding: regional distribution in monkey brain, Brain Res., 66: 541.
Zarbin, M.A., Wamsley, J.K., and Kuhar, M.J., 1982, Axonal transport of muscarinic cholinergic receptors in rat vagus nerve: high and low affinity agonist receptors move in opposite directions and differ in nucleotide sensitivity, J. Neurosci., 2: 934.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pepeu, G., Pepeu, I.M. (1984). The Muscarinic Receptors. In: Cattabeni, F., Nicosia, S. (eds) Principles and Methods in Receptor Binding. NATO ASI Series, vol 72. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1577-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1577-4_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1579-8
Online ISBN: 978-1-4757-1577-4
eBook Packages: Springer Book Archive